Meanwhile, the metabolic characteristics of anti-MDA5, anti-TIF1-γ, and anti-Jo-1 positive DM were studied to explore the key metabolic pathways that promote the development of the disease. This evidence concerns the gene TRIM33 and dermatomyositis.